Tokyo Tape
Sign in
← Hokuyaku Takeyama Holdings

Quarterly report · Q3

3055.TEDINET S100Q3RS
Period2022-04-01 → 2022-12-31
Filed2023-02-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥198.6bn2022-04-01 → 2022-12-31Cons.Net sales
Revenue¥248.4bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥188.6bn2021-04-01 → 2021-12-31Cons.Net sales
Operating income¥2.2bn2022-04-01 → 2022-12-31Cons.Operating income
Operating income¥1.7bn2021-04-01 → 2021-12-31Cons.Operating income
Ordinary income¥3.2bn2022-04-01 → 2022-12-31Cons.Ordinary income
Ordinary income¥3.4bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥2.7bn2021-04-01 → 2021-12-31Cons.Ordinary income
Profit before tax¥3.6bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Profit before tax¥3.0bn2021-04-01 → 2021-12-31Cons.Income before income taxes
Net income (owners)¥2.4bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.8bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥2.1bn2021-04-01 → 2021-12-31Cons.Profit loss attributable to owners of parent
Net income¥2.4bn2022-04-01 → 2022-12-31Cons.Profit loss
Net income¥2.1bn2021-04-01 → 2021-12-31Cons.Profit loss
Total assets¥146.6bnat 2022-12-31Cons.Assets
Total assets¥136.9bnat 2022-03-31Cons.Assets
Total assets¥142.2bnat 2021-12-31Cons.Total assets (5-year summary)
Total liabilities¥89.0bnat 2022-12-31Cons.Liabilities
Total liabilities¥81.3bnat 2022-03-31Cons.Liabilities
Net assets / equity¥57.6bnat 2022-12-31Cons.Net assets
Net assets / equity¥55.5bnat 2022-03-31Cons.Net assets
Net assets / equity¥55.5bnat 2021-12-31Cons.Net assets (5-year summary)
Cash and deposits¥21.4bnat 2022-12-31Cons.Cash and deposits
Cash and deposits¥21.1bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥21.4bnat 2022-12-31Cons.Cash and cash equivalents
Cash & equivalents¥21.1bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥20.7bnat 2021-12-31Cons.Cash and cash equivalents
Cash & equivalents¥20.4bnat 2021-03-31dCons.Cash and cash equivalents
Operating cash flow¥2.0bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in operating activities
Operating cash flow¥3.2bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥1.6bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥856m2022-04-01 → 2022-12-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥1.7bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥491m2021-04-01 → 2021-12-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥808m2022-04-01 → 2022-12-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥849m2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥824m2021-04-01 → 2021-12-31Cons.Net cash provided by used in financing activities
EPS (basic)¥109.942022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥46.722022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥123.442021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥90.42021-04-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥38.442021-10-01 → 2021-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio39.3%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio40.6%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio39.1%at 2021-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 56
SegmentItemPeriodValue
Otherother segmentsrevenue2022-04-01 → 2022-12-31¥1.9bn
Otherother segmentsrevenue external2022-04-01 → 2022-12-31¥46m
Otherother segmentsrevenue intersegment2022-04-01 → 2022-12-31¥1.8bn
Otherother segmentssegment profit2022-04-01 → 2022-12-31¥819m
jpcrp040300-q3r_E03003-000Dispensing Industryreportable segmentrevenue2022-04-01 → 2022-12-31¥10.2bn
jpcrp040300-q3r_E03003-000Dispensing Industryreportable segmentrevenue external2022-04-01 → 2022-12-31¥10.2bn
jpcrp040300-q3r_E03003-000Dispensing Industryreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥9m
jpcrp040300-q3r_E03003-000Dispensing Industryreportable segmentsegment profit2022-04-01 → 2022-12-31−¥14m
jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segmentrevenue2022-04-01 → 2022-12-31¥1.2bn
jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segmentrevenue external2022-04-01 → 2022-12-31¥362m
jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥825m
jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segmentsegment profit2022-04-01 → 2022-12-31¥25m
jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segmentrevenue2022-04-01 → 2022-12-31¥49.2bn
jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segmentrevenue external2022-04-01 → 2022-12-31¥48.9bn
jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥379m
jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segmentsegment profit2022-04-01 → 2022-12-31¥1.1bn
jpcrp040300-q3r_E03003-000Nursing Industryreportable segmentrevenue2022-04-01 → 2022-12-31¥3.0bn
jpcrp040300-q3r_E03003-000Nursing Industryreportable segmentrevenue external2022-04-01 → 2022-12-31¥3.0bn
jpcrp040300-q3r_E03003-000Nursing Industryreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥2m
jpcrp040300-q3r_E03003-000Nursing Industryreportable segmentsegment profit2022-04-01 → 2022-12-31¥295m
jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segmentrevenue2022-04-01 → 2022-12-31¥143.0bn
jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segmentrevenue external2022-04-01 → 2022-12-31¥136.1bn
jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥6.9bn
jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segmentsegment profit2022-04-01 → 2022-12-31¥1.1bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥208.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥198.6bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥9.9bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥3.3bn
Otherother segmentsrevenue2021-04-01 → 2021-12-31¥1.3bn
Otherother segmentsrevenue external2021-04-01 → 2021-12-31¥45m
Otherother segmentsrevenue intersegment2021-04-01 → 2021-12-31¥1.2bn
Otherother segmentssegment profit2021-04-01 → 2021-12-31¥264m
jpcrp040300-q3r_E03003-000Dispensing Industryreportable segmentrevenue2021-04-01 → 2021-12-31¥10.3bn
jpcrp040300-q3r_E03003-000Dispensing Industryreportable segmentrevenue external2021-04-01 → 2021-12-31¥10.3bn
jpcrp040300-q3r_E03003-000Dispensing Industryreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥10m
jpcrp040300-q3r_E03003-000Dispensing Industryreportable segmentsegment profit2021-04-01 → 2021-12-31¥122m
jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segmentrevenue2021-04-01 → 2021-12-31¥1.0bn
jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segmentrevenue external2021-04-01 → 2021-12-31¥331m
jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥700m
jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segmentsegment profit2021-04-01 → 2021-12-31¥60m
jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segmentrevenue2021-04-01 → 2021-12-31¥47.2bn
jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segmentrevenue external2021-04-01 → 2021-12-31¥46.9bn
jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥350m
jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segmentsegment profit2021-04-01 → 2021-12-31¥875m
jpcrp040300-q3r_E03003-000Nursing Industryreportable segmentrevenue2021-04-01 → 2021-12-31¥2.9bn
jpcrp040300-q3r_E03003-000Nursing Industryreportable segmentrevenue external2021-04-01 → 2021-12-31¥2.8bn
jpcrp040300-q3r_E03003-000Nursing Industryreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥6m
jpcrp040300-q3r_E03003-000Nursing Industryreportable segmentsegment profit2021-04-01 → 2021-12-31¥272m
jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segmentrevenue2021-04-01 → 2021-12-31¥135.0bn
jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segmentrevenue external2021-04-01 → 2021-12-31¥128.2bn
jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥6.8bn
jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segmentsegment profit2021-04-01 → 2021-12-31¥577m
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-12-31¥197.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-12-31¥188.6bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-12-31¥9.1bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-12-31¥2.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 514
ItemContextValueUnit
Income taxes currentPrior1YTDDuration864000000JPY
Income taxes currentCurrentYTDDuration923000000JPY
Income taxes deferredPrior1YTDDuration93000000JPY
Income taxes deferredCurrentYTDDuration254000000JPY
Income taxesPrior1YTDDuration958000000JPY
Income taxesCurrentYTDDuration1178000000JPY
Profit lossPrior1YTDDuration2059000000JPY
Profit lossCurrentYTDDuration2438000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration1000000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration1000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration2057000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration2436000000JPY
Profit lossPrior1YTDDuration2059000000JPY
Profit lossCurrentYTDDuration2438000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration-106000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration328000000JPY
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration12000000JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration14000000JPY
Other comprehensive incomePrior1YTDDuration-94000000JPY
Other comprehensive incomeCurrentYTDDuration343000000JPY
Comprehensive incomePrior1YTDDuration1965000000JPY
Comprehensive incomeCurrentYTDDuration2781000000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration1963000000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration2779000000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration1000000JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration1000000JPY
Income before income taxesPrior1YTDDuration3017000000JPY
Income before income taxesCurrentYTDDuration3616000000JPY
Depreciation and amortization ope cfPrior1YTDDuration805000000JPY
Depreciation and amortization ope cfCurrentYTDDuration804000000JPY
Amortization of goodwill ope cfPrior1YTDDuration84000000JPY
Amortization of goodwill ope cfCurrentYTDDuration83000000JPY
Increase decrease in allowance for doubtful accounts ope cfPrior1YTDDuration-32000000JPY
Increase decrease in allowance for doubtful accounts ope cfCurrentYTDDuration-17000000JPY
Interest and dividends income ope cfPrior1YTDDuration-266000000JPY
Interest and dividends income ope cfCurrentYTDDuration-276000000JPY
Interest expenses ope cfPrior1YTDDuration0JPY
Interest expenses ope cfCurrentYTDDuration0JPY
Equity in earnings losses of affiliates ope cfPrior1YTDDuration-95000000JPY
Equity in earnings losses of affiliates ope cfCurrentYTDDuration-88000000JPY
Loss gain on sales of noncurrent assets ope cfPrior1YTDDuration-76000000JPY
Loss gain on sales of noncurrent assets ope cfCurrentYTDDuration0JPY
Loss on retirement of noncurrent assets ope cfPrior1YTDDuration111000000JPY
Loss on retirement of noncurrent assets ope cfCurrentYTDDuration1000000JPY
Loss gain on sales of investment securities ope cfPrior1YTDDuration-378000000JPY
Loss gain on sales of investment securities ope cfCurrentYTDDuration-385000000JPY
Impairment loss ope cfPrior1YTDDuration2000000JPY
Impairment loss ope cfCurrentYTDDuration－JPY
Decrease increase in notes and accounts receivable trade ope cfPrior1YTDDuration-6195000000JPY
Decrease increase in notes and accounts receivable trade ope cfCurrentYTDDuration-5988000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-12-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2021-04-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass